AVCNF - Avicanna Announces Results of Annual General Meeting & Provides Corporate Update | Benzinga
TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that all of management's nominees listed in the Company's Management Information Circular dated May 31, 2024 ("Circular") were elected as directors of the Company at the Company's Annual General Meeting of Shareholders held on July 10, 2024 ("Meeting").
The detailed results of the vote for the election of directors held at the Meeting are as follows:
| Name of NOMINEE |
| # Votes Cast FOR |
| % Votes Cast FOR |
| # Votes WITHHELD |
| % Votes WITHHELD |
| Aras Azadian |
| 17,347,064 |
| 99.99% |
| 2,019 |
| 0.01% |
| Giancarlo Davila Char |
| 17,320,064 |